Hung Tseng to Case-Control Studies
This is a "connection" page, showing publications Hung Tseng has written about Case-Control Studies.
Connection Strength
0.864
-
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat Commun. 2023 Jan 12; 14(1):189.
Score: 0.173
-
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ. 2021 12 15; 375:e068848.
Score: 0.160
-
Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018. Vaccine. 2019 09 16; 37(39):5807-5811.
Score: 0.136
-
Family history of zoster and risk of developing herpes zoster. Int J Infect Dis. 2018 Jan; 66:99-106.
Score: 0.121
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.098
-
Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Pediatr Infect Dis J. 2010 Mar; 29(3):205-8.
Score: 0.071
-
Risk factors for anal cancer: results of a population-based case--control study. Cancer Causes Control. 2003 Nov; 14(9):837-46.
Score: 0.046
-
Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era. Pediatrics. 2016 Apr; 137(4).
Score: 0.027
-
End-stage renal disease in Taiwan: a case-control study. J Epidemiol. 2009; 19(4):169-76.
Score: 0.017
-
Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med. 2008 May; 37(5):271-7.
Score: 0.016